The activation index in each condition was evaluated by determining the percentage of bromodeoxyuridine (BrdU)-positive cells, indicative of the cell-activation response to HGF samples
It's manufactured in FDA-registered facilities in the U.S., which at least removes some guesswork about quality control
It is non-GMO and does not contain milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, or soy, making it suitable for individuals with common dietary sensitivities
A single A nucleotide is added to the 3 ends of the blunt fragments at 37 C for 30 min
Some clinicians and podcasters speak about it as if it were a quietly acknowledged frontier therapy that regulators are sitting on for reasons of patent, profit, or institutional suppression